GO:0034638 phosphatidylcholine catabolic process: Lipid Breakdown Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034638 (phosphatidylcholine catabolic process) describes the biochemical breakdown of phosphatidylcholines, glycerophospholipids in which the phosphatidyl group is esterified to choline.
• Phosphatidylcholine catabolism supplies choline, fatty acids, diacylglycerol and lysophosphatidylcholine for membrane remodeling, lipid droplet dynamics and one-carbon metabolism.
• The process is coordinated with phosphatidylcholine biosynthesis and with lipophagy, which can fuel phosphatidylcholine synthesis during viral replication.
• Dysregulation of phosphatidylcholine catabolic flux is linked to metabolic associated fatty liver disease, where polyene phosphatidylcholine plus atorvastatin improves clinical parameters.
• Key experimental tools include SERS-based dynamic monitoring of phosphatidylcholine oxidation, lipid droplet imaging, and CRISPR knockout or knock-in models of catabolic enzymes.
• EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models and CRISPR library screening to dissect phosphatidylcholine catabolic process genes.
Description
Phosphatidylcholine (PC) is the most abundant glycerophospholipid in eukaryotic membranes, and its controlled breakdown is essential for membrane homeostasis, lipid signaling and energy metabolism. GO:0034638, phosphatidylcholine catabolic process, is the biological process ontology term that captures the chemical reactions and pathways resulting in the breakdown of phosphatidylcholines, defined as glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline. Researchers study this term because catabolic flux through PC pools determines the availability of choline for one-carbon metabolism, of fatty acids for oxidation or storage, and of lysophosphatidylcholine and diacylglycerol for signaling and membrane remodeling. The process is not merely degradative; it is dynamically coupled to PC biosynthesis and to lipid droplet turnover. For example, lipophagy can fuel phosphatidylcholine synthesis for Newcastle disease virus replication, showing that catabolic and anabolic arms of PC metabolism are functionally intertwined. Phosphatidylcholine also coordinates endoplasmic reticulum autonomous and non-autonomous adaptations to unfolded protein response dysfunction, linking PC catabolic and biosynthetic balance to proteostasis. In bacteria, phosphatidylcholine biosynthesis and function have been reviewed as a distinct metabolic module, underscoring the evolutionary breadth of PC metabolism. From a translational perspective, altered PC catabolism is relevant to metabolic associated fatty liver disease, where polyene phosphatidylcholine combined with atorvastatin has shown clinical efficacy and mechanistic effects on lipid handling. One-carbon cycle metabolites that methylate their way to fatty liver further connect choline-derived methyl groups to hepatic lipid accumulation. Because PC catabolic enzymes and their regulators are druggable and measurable, GO:0034638 is a high-value target space for CRISPR-based functional genomics and for lipidomic biomarker discovery.
phosphatidylcholine catabolic process At A Glance
| GO ID | GO:0034638 |
|---|---|
| GO term | phosphatidylcholine catabolic process |
| Ontology | biological_process |
| Synonym | phosphatidylcholine breakdown; phosphatidylcholine catabolism; phosphatidylcholine degradation |
| Definition | The chemical reactions and pathways resulting in the breakdown of phosphatidylcholines, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline. |
| Major function | Generates choline, fatty acids, lysophosphatidylcholine and diacylglycerol for membrane remodeling, lipid signaling, lipid droplet dynamics and one-carbon metabolism. |
| Related process | Coupled to phosphatidylcholine biosynthesis and lipophagy, which can fuel PC synthesis during viral replication. |
| Disease relevance | Metabolic associated fatty liver disease and hepatic lipid accumulation linked to one-carbon metabolism. |
| Detection method | SERS can dynamically monitor phosphatidylcholine oxidation, and lipid droplet imaging tracks PC-derived neutral lipids. |
What Is GO:0034638?
GO:0034638 phosphatidylcholine catabolic process is the biological process comprising the chemical reactions and pathways that result in the breakdown of phosphatidylcholines, a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline. In practical terms, it covers enzymatic and non-enzymatic routes that hydrolyze or oxidize PC, releasing choline, free fatty acids, lysophosphatidylcholine, diacylglycerol, glycerophosphocholine or oxidized PC species, and it is synonymous with phosphatidylcholine breakdown, phosphatidylcholine catabolism and phosphatidylcholine degradation.
Why Is phosphatidylcholine catabolic process Important in Cell Biology?
Phosphatidylcholine catabolic process matters because it controls the size, composition and signaling output of the largest glycerophospholipid pool in cells, and because its products feed directly into choline-dependent one-carbon metabolism, fatty acid oxidation and lipid droplet biology. Perturbations in this process are associated with metabolic associated fatty liver disease, where polyene phosphatidylcholine combined with atorvastatin has measurable clinical and mechanistic effects. The process also intersects with the unfolded protein response and with viral replication through lipophagy-driven PC synthesis, making it a central node in cell stress and infection biology. Finally, because PC catabolism can be monitored dynamically by SERS and by lipid droplet imaging, it is experimentally tractable for CRISPR screens and lipidomic validation.
• Maintains membrane phospholipid homeostasis by balancing PC breakdown with PC biosynthesis.
• Supplies choline for one-carbon metabolism and methylation reactions relevant to fatty liver.
• Generates lysophosphatidylcholine and diacylglycerol as lipid signaling intermediates.
• Connects to lipid droplet dynamics and neutral lipid storage.
• Is functionally coupled to lipophagy, which can fuel PC synthesis during Newcastle disease virus replication.
• Contributes to endoplasmic reticulum adaptation when unfolded protein response is dysfunctional.
• Is relevant to metabolic associated fatty liver disease and to polyene phosphatidylcholine-based therapy.
• Can be monitored dynamically using SERS during PC oxidation.
• Is conserved across taxa, including bacterial phosphatidylcholine metabolism.
• Provides a tractable target space for CRISPR knockout, knock-in and overexpression studies.
What Happens During phosphatidylcholine catabolic process?
Substrate recognition and phospholipase action
In simple terms: Enzymes first grab the phosphatidylcholine molecule and cut it at specific positions.
Phosphatidylcholine catabolic process begins when phospholipases and related lipases recognize PC as a substrate and hydrolyze its ester bonds, releasing lysophosphatidylcholine, free fatty acids, diacylglycerol or glycerophosphocholine. Because PC is a glycerophospholipid with the phosphatidyl group esterified to choline, the cleavage position determines which lipid products enter signaling versus storage pathways. Reviews of phosphatidylcholine functions beyond its role as a membrane brick emphasize that these cleavage products are bioactive rather than mere waste.
Oxidation and non-enzymatic breakdown
In simple terms: Phosphatidylcholine can also be broken down by oxidation, not just by enzymes.
Oxidative modification of phosphatidylcholine is a distinct catabolic route that generates oxidized PC species and truncated acyl chains. SERS analysis has been used to dynamically monitor the oxidation process of phosphatidylcholine, providing real-time spectral evidence of PC breakdown. This oxidative arm is relevant to oxidative stress biology and to the interpretation of lipidomic datasets where oxidized PC species appear alongside enzymatically generated lysophosphatidylcholine.
Product partitioning into lipid droplets and membranes
In simple terms: The breakdown products are sorted into storage droplets or back into membranes.
Catabolic products of phosphatidylcholine are partitioned between membrane remodeling and lipid droplet storage. Phospholipids and lipid droplets are functionally linked, and PC-derived diacylglycerol and fatty acids can be esterified into neutral lipids within lipid droplets. This partitioning determines whether PC catabolism supports membrane expansion, energy storage or signaling, and it is a key node for experimental perturbation.
Coupling to biosynthesis and lipophagy
In simple terms: Breakdown and rebuilding of phosphatidylcholine are connected, sometimes through autophagy of lipid droplets.
Phosphatidylcholine catabolic process is coupled to PC biosynthesis, and lipophagy can fuel phosphatidylcholine synthesis for Newcastle disease virus replication. In addition, phosphatidylcholine coordinates endoplasmic reticulum autonomous and non-autonomous adaptations to unfolded protein response dysfunction, showing that catabolic and biosynthetic PC fluxes are integrated with proteostasis. This coupling means that measuring catabolism alone can be misleading without parallel measurement of synthesis.
Choline release and one-carbon metabolism
In simple terms: Breaking down phosphatidylcholine releases choline that feeds methylation chemistry.
A major endpoint of phosphatidylcholine catabolic process is the release of free choline, which enters the one-carbon cycle and supports methylation reactions. One-carbon cycle metabolites methylate their way to fatty liver, linking choline availability to hepatic lipid accumulation. This connection explains why perturbations in PC catabolism can have systemic metabolic consequences beyond the membrane.
Key Genes Involved in GO:0034638 phosphatidylcholine catabolic process
The genes and proteins below represent the major enzymatic, transport and regulatory nodes experimentally associated with phosphatidylcholine catabolic process and its coupling to biosynthesis, lipid droplets and one-carbon metabolism.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PLA2G4A | Cytosolic phospholipase A2 that hydrolyzes PC to release arachidonic acid and lysophosphatidylcholine | Inflammation and lipid signaling studies; knockout models reduce lysophosphatidylcholine production |
| PLA2G6 | Calcium-independent phospholipase A2 involved in PC remodeling and catabolism | Neurodegeneration and membrane homeostasis models |
| PNPLA2 | Adipose triglyceride lipase with phospholipase activity contributing to lipid droplet PC hydrolysis | Lipid droplet dynamics and lipophagy research |
| LPL | Lipoprotein lipase that hydrolyzes PC-rich lipoprotein surfaces | Lipoprotein metabolism and fatty liver models |
| LCAT | Lecithin-cholesterol acyltransferase that transfers acyl chains from PC to cholesterol | Reverse cholesterol transport and PC catabolism studies |
| PLD1 | Phospholipase D that hydrolyzes PC to phosphatidic acid and choline | Signaling and membrane trafficking studies |
| PLD2 | Phospholipase D isoform contributing to PC-derived phosphatidic acid production | Cell signaling and vesicle trafficking |
| CHKA | Choline kinase alpha, first step of PC biosynthesis, whose balance with catabolism sets PC pool size | Metabolic flux and CRISPR knockout studies |
| PCYT1A | CTP:phosphocholine cytidylyltransferase, rate-limiting PC biosynthesis enzyme | Coupling of catabolism to biosynthesis |
| CEPT1 | Choline/ethanolamine phosphotransferase for PC synthesis | Membrane lipid homeostasis models |
| LPCAT1 | Lysophosphatidylcholine acyltransferase that reacylates PC breakdown products | PC remodeling and lipid droplet studies |
| ABHD5 | Activator of PNPLA2 and regulator of lipid droplet lipolysis | Lipophagy and lipid droplet catabolism |
| SQSTM1 | Autophagy receptor linking lipid droplets to lipophagy | Lipophagy-driven PC synthesis research |
| MAP1LC3B | Autophagosome marker required for lipophagy | Lipophagy and PC catabolism coupling |
| XBP1 | Unfolded protein response transcription factor coordinating ER lipid adaptation | PC catabolism and ER stress studies |
| MTHFR | One-carbon cycle enzyme influencing methylation and choline metabolism | Fatty liver and one-carbon metabolism research |
| BHMT | Betaine-homocysteine methyltransferase linking choline catabolism to methionine cycle | Hepatic lipid accumulation models |
| PEMT | Phosphatidylethanolamine N-methyltransferase that synthesizes PC from PE | PC biosynthesis-catabolism balance studies |
How Is phosphatidylcholine catabolic process Regulated?
Phosphatidylcholine catabolic process is regulated at multiple levels. Transcriptionally and post-translationally, phospholipase activities respond to lipid demand, inflammatory signals and membrane stress, and the balance between PC catabolism and biosynthesis is adjusted to maintain membrane composition. Lipophagy provides a regulatory route by which lipid droplets are delivered to autophagosomes and their contents are used to fuel phosphatidylcholine synthesis, as shown for Newcastle disease virus replication. The unfolded protein response also intersects with PC metabolism, since phosphatidylcholine coordinates endoplasmic reticulum autonomous and non-autonomous adaptations to unfolded protein response dysfunction. In addition, one-carbon cycle metabolites that methylate their way to fatty liver indicate that choline released by PC catabolism feeds methylation reactions that can feedback on hepatic lipid handling. Together, these layers make PC catabolism a responsive, context-dependent process rather than a constitutive housekeeping pathway.
phosphatidylcholine catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PLA2G4A | Inflammatory lipid signaling via lysophosphatidylcholine release | Knockout cell model with lipidomic readout |
| PNPLA2 | Lipid droplet catabolism and lipophagy | Knockout and tagged knock-in models |
| LCAT | Lipoprotein PC catabolism and cholesterol transport | Point-mutation knock-in cell model |
| XBP1 | ER stress adaptation linked to PC metabolism | Knockout and overexpression models |
| MTHFR | One-carbon metabolism and fatty liver | Knockout cell model with methylation assays |
Metabolic associated fatty liver disease
Phosphatidylcholine catabolic process is directly relevant to metabolic associated fatty liver disease because PC turnover influences hepatic lipid accumulation and choline availability. Polyene phosphatidylcholine combined with atorvastatin has shown clinical efficacy and mechanistic effects in treating metabolic associated fatty liver disease, supporting the therapeutic relevance of PC metabolism. One-carbon cycle metabolites that methylate their way to fatty liver further connect choline-derived methyl groups to hepatic steatosis. Experimental models can test whether altering PC catabolic flux changes liver lipid content.
Viral replication and host lipid remodeling
Lipophagy can fuel phosphatidylcholine synthesis for Newcastle disease virus replication, demonstrating that PC metabolic flux is co-opted by viruses. This finding implies that phosphatidylcholine catabolic process and its coupling to biosynthesis are part of host-pathogen lipid remodeling, and that perturbing catabolic enzymes could affect viral replication efficiency. The same logic may apply to other enveloped viruses that depend on host membrane lipids.
Endoplasmic reticulum stress and proteostasis
Phosphatidylcholine coordinates endoplasmic reticulum autonomous and non-autonomous adaptations to unfolded protein response dysfunction, linking PC metabolism to proteostasis. Because PC catabolic and biosynthetic fluxes shape ER membrane composition, altered catabolism can modify ER stress responses and cell survival. This makes PC catabolic genes candidate modifiers in diseases characterized by chronic ER stress.
Oxidative stress and lipid oxidation
Oxidative breakdown of phosphatidylcholine generates oxidized lipid species that can propagate membrane damage. SERS analysis has been used to dynamically monitor the oxidation process of phosphatidylcholine, providing a method to quantify this catabolic route. Oxidized PC species are relevant to inflammation and to the interpretation of lipidomic signatures in disease.
From phosphatidylcholine catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a phospholipase alter PC catabolic flux? | CRISPR knockout cell model with lipidomics |
| Does a disease-associated point mutation change enzyme activity? | Point-mutation knock-in cell model |
| Can a tagged catabolic enzyme be tracked in live cells? | Tagged knock-in with fluorescent or affinity tag |
| Does overexpression of a PC catabolic gene change lipid droplet content? | Overexpression cell model with imaging |
| Which genes modify PC catabolism under ER stress? | CRISPR library screening with ER stress selection |
| Does lipophagy contribute to PC-derived synthesis? | Knockout of autophagy genes plus lipid flux tracing |
How to Study the phosphatidylcholine catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS) | PC species and catabolic products | Quantify knockout effects on PC breakdown |
| SERS | Dynamic oxidation of phosphatidylcholine | Real-time monitoring of PC oxidation |
| Fluorescence imaging | Lipid droplet and membrane dynamics | Track PC-derived lipid partitioning |
| Stable-isotope tracing | Flux through PC catabolic and biosynthetic routes | Determine pathway directionality |
| CRISPR knockout screening | Gene requirement for PC catabolic phenotypes | Identify novel regulators |
| Tagged knock-in imaging | Subcellular localization of catabolic enzymes | Study lipophagy and organelle contact sites |
| One-carbon metabolite assays | Choline-derived methylation intermediates | Link PC catabolism to fatty liver |
| Western blot and qPCR | Expression of PC catabolic genes | Validate CRISPR perturbations |
Lipidomics and SERS monitoring
Mass spectrometry-based lipidomics quantifies phosphatidylcholine species and their catabolic products, including lysophosphatidylcholine, diacylglycerol and free fatty acids. SERS analysis provides dynamic, label-free monitoring of the oxidation process of phosphatidylcholine, complementing endpoint lipidomics. Together these methods define the substrate-product landscape of GO:0034638.
Imaging of lipid droplets and membranes
Fluorescence imaging of lipid droplets and membrane probes reveals how PC catabolic flux redistributes neutral lipids and membrane lipids. Tagged knock-in of catabolic enzymes allows co-localization with lipid droplets and autophagosomes, which is especially informative for lipophagy studies. Time-lapse imaging can capture dynamic changes after CRISPR perturbation.
CRISPR screening and functional genomics
Pooled CRISPR knockout or activation screens can identify genes that modify PC catabolic flux or sensitivity to lipid stress. Hits are validated individually with lipidomic and imaging readouts, and candidate genes can be prioritized by pathway annotation to GO:0034638. This workflow connects genotype to lipid phenotype at scale.
Metabolic tracing and one-carbon assays
Stable-isotope tracing of choline and fatty acid moieties measures flux through PC catabolic and biosynthetic pathways. One-carbon cycle metabolite assays link choline release to methylation status, which is relevant to fatty liver models. Combining tracing with CRISPR perturbation provides causal evidence for gene function in PC catabolism.
How CRISPR Can Be Used to Study GO:0034638 phosphatidylcholine catabolic process
Knockout
CRISPR knockout of phosphatidylcholine catabolic genes such as phospholipases and lipases removes enzymatic activity and reveals its contribution to PC turnover, lipid droplet content and downstream signaling. Knockout cell models are typically validated by lipidomics and imaging, and they can be used to test whether a gene is required for lipophagy-driven PC synthesis. Knockout of one-carbon cycle genes can also reveal how choline released by PC catabolism feeds methylation.
Point Mutation
Point-mutation knock-in models introduce disease-associated or catalytic-dead variants of PC catabolic enzymes to separate enzymatic activity from scaffolding functions. These models are valuable when a human variant is suspected to alter PC catabolism but the mechanism is unclear. Point mutations in one-carbon cycle enzymes can similarly test effects on choline-dependent methylation.
Knock-in
Knock-in of fluorescent or affinity tags at endogenous loci enables tracking of PC catabolic enzymes in live cells and mapping their proximity to lipid droplets and autophagosomes. Tagged knock-in avoids overexpression artifacts and preserves endogenous regulation, which is important for a flux-dependent process like GO:0034638. Knock-in of reporter cassettes can also provide transcriptional readouts of catabolic gene activity.
Overexpression
Overexpression of PC catabolic enzymes or their regulators tests sufficiency for increased PC breakdown, lipid droplet remodeling or ER stress adaptation. Overexpression models are useful for producing sufficient material for biochemical assays and for testing whether a gene can drive a phenotype alone. Combining overexpression with lipidomics and SERS readouts links enzyme abundance to catabolic flux.
How EDITGENE Supports phosphatidylcholine catabolic process Research
Researchers studying phosphatidylcholine catabolic process-related genes often need to determine whether a candidate gene is causally involved in PC breakdown, whether a specific variant alters enzyme function, and how loss or gain of function reshapes lipid flux. EDITGENE provides publication-ready CRISPR cell models and screening services tailored to these questions, from single-gene knockout to genome-wide library screening and bioinformatic prioritization.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylcholine catabolic process research.
Frequently Asked Questions About phosphatidylcholine catabolic process
What is phosphatidylcholine catabolic process?
It is the biological process GO:0034638, defined as the chemical reactions and pathways resulting in the breakdown of phosphatidylcholines, glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline.
What is the GO ID for phosphatidylcholine catabolic process?
The GO ID is GO:0034638, under the biological_process ontology.
What genes are involved in phosphatidylcholine catabolic process?
Genes include phospholipases such as PLA2G4A and PLD1, lipid droplet lipases such as PNPLA2, and enzymes that reacylate or synthesize PC such as LPCAT1 and PCYT1A, as well as one-carbon cycle genes like MTHFR.
Why is phosphatidylcholine catabolism important for cells?
It supplies choline, fatty acids, lysophosphatidylcholine and diacylglycerol for membrane remodeling, signaling, lipid droplet dynamics and one-carbon metabolism.
How is phosphatidylcholine catabolic process measured?
It can be measured by lipidomics, SERS-based dynamic monitoring of PC oxidation, fluorescence imaging of lipid droplets, and stable-isotope tracing.
Is phosphatidylcholine catabolism linked to fatty liver disease?
Yes, polyene phosphatidylcholine combined with atorvastatin has shown clinical efficacy in metabolic associated fatty liver disease, and one-carbon metabolites link choline metabolism to fatty liver.
How does lipophagy relate to phosphatidylcholine metabolism?
Lipophagy can fuel phosphatidylcholine synthesis for Newcastle disease virus replication, showing that autophagic lipid breakdown is coupled to PC anabolism.
Can phosphatidylcholine be broken down by oxidation?
Yes, SERS analysis has been used to dynamically monitor the oxidation process of phosphatidylcholine, which is a non-enzymatic catabolic route.
What CRISPR models are useful for studying phosphatidylcholine catabolic process?
Knockout, point-mutation knock-in, tagged knock-in and overexpression cell models, plus CRISPR library screening, are all suitable for dissecting GO:0034638.
Does phosphatidylcholine catabolism affect the unfolded protein response?
Phosphatidylcholine coordinates endoplasmic reticulum autonomous and non-autonomous adaptations to unfolded protein response dysfunction, linking PC metabolism to ER stress.
Conclusion
GO:0034638 phosphatidylcholine catabolic process is a central lipid metabolic pathway that converts phosphatidylcholine into choline, fatty acids, lysophosphatidylcholine and diacylglycerol, feeding membrane remodeling, lipid droplet dynamics, one-carbon metabolism and stress adaptation. Its coupling to PC biosynthesis and lipophagy, its relevance to fatty liver disease and viral replication, and its tractability with SERS, lipidomics and CRISPR models make it a high-value research area. Systematic CRISPR perturbation combined with lipidomic and imaging readouts will continue to define the genes and regulatory logic of this process.
References
- 1. Xiang S et al.. 2018. Dynamic Monitoring of the Oxidation Process of Phosphatidylcholine Using SERS Analysis.. Anal Chem 90(22):13751-13758 PMID: 30350609
- 2. Penno A et al.. 2013. Phospholipids and lipid droplets.. Biochim Biophys Acta 1831(3):589-94 PMID: 23246574
- 3. Yang M et al.. 2026. Lipophagy fuels phosphatidylcholine synthesis for Newcastle disease virus replication.. Autophagy 22(6):1351-1368 PMID: 41810751
- 4. Cheng C et al.. 2026. Clinical efficacy and mechanism of polyene phosphatidylcholine combined with atorvastatin in treating metabolic associated fatty liver disease.. Pak J Pharm Sci 39(2):415-420 PMID: 41546577
- 5. Geiger O et al.. 2013. Phosphatidylcholine biosynthesis and function in bacteria.. Biochim Biophys Acta 1831(3):503-13 PMID: 22922101
- 6. Tong H et al.. 2026. Phosphatidylcholine coordinates ER-autonomous and ER-nonautonomous adaptations to unfolded protein response dysfunction.. J Biol Chem 302(1):111026 PMID: 41360263
- 7. Furse S et al.. 2015. Phosphatidylcholine's functions beyond that of a membrane brick.. Mol Membr Biol 32(4):117-9 PMID: 26306852
- 8. Walker AK. 2017. 1-Carbon Cycle Metabolites Methylate Their Way to Fatty Liver.. Trends Endocrinol Metab 28(1):63-72 PMID: 27789099
